Position in HIMS
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$1,879,734
+$203,763 QoQ
Shares Held
90,546
+75.4% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MML INVESTORS SERVICES, LLC holds $17,040,391 across 15 Drug Manufacturers - Specialty & Generic names. HIMS ranks #3 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
39,210 | $4,635,014 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
66,778 | $2,011,353 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
This page
|
90,546 | $1,879,734 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
2,952 | $1,750,476 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
77,465 | $1,434,651 | |
| 6 | HLN |
Haleon plc
|
119,786 | $1,199,057 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
89,343 | $1,110,533 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
8,151 | $1,073,812 |
All Filings in HIMS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,879,734 | 90,546 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $1,675,971 | 51,616 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $944,841 | 16,658 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,224,764 | 24,569 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $351,645 | 11,900 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $230,169 | 9,519 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $196,615 | 10,674 | Shares | Defined | 2024-11-15 | |
| No filing history on record for this holder in this stock. | ||||||